COVID-19 is associated with cardiac structural and functional remodelling in healthy middle-aged and older

Mushidur Rahman1,2, Sophie L Russell1,2, Nduka C Okwose1,2

  • 1Research Centre for Health and Life Sciences, Institute for Health and Wellbeing, Coventry University, Coventry, UK.

Insights

History of COVID-19 in middle-aged and older adults is linked to cardiac structural changes, including increased left ventricular mass and reduced global longitudinal strain, despite normal ejection fraction. This indicates potential cardiac remodeling post-infection.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Cardiovascular Imaging

Background:

  • Coronavirus disease 2019 (COVID-19) became a global pandemic in 2019.
  • The cardiac impact of COVID-19 in healthy individuals remains unclear.
  • This study focuses on middle-aged and older adults.

Purpose of the Study:

  • To evaluate the effect of COVID-19 on cardiac structure and function.
  • To assess cardiac changes in middle-aged and older individuals post-COVID-19.

Main Methods:

  • A prospective observational study included 124 participants (84 COVID-19 positive, 40 controls).
  • Echocardiography with speckle tracking was used to assess cardiac structure and function.
  • Measurements were taken at rest and during peak exercise.

Main Results:

  • COVID-19 survivors showed increased left ventricular mass and relative wall thickness.
  • Reduced left ventricular global longitudinal strain was observed at rest and peak exercise.
  • Right ventricular fractional area change was also reduced in the COVID-19 group.

Conclusions:

  • Cardiac structural and functional remodeling occurs in healthy middle-aged and older individuals after COVID-19.
  • Findings suggest a need for monitoring cardiac health in post-COVID-19 patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
8
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3